Skip to main content
Erschienen in: International Journal of Legal Medicine 3/2019

20.09.2018 | Original Article

Postmortem interrogation of cardiac implantable electrical devices may clarify time and cause of death

verfasst von: Lisa Riesinger, S. Fichtner, C. G. Schuhmann, H. L. Estner, T. Czermak, M. Graw, F. Fischer, K. Lackermair

Erschienen in: International Journal of Legal Medicine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Postmortem interrogation of cardiac implantable electrical devices (CIED) in autopsy is not routinely performed. Thus, it remains unclear whether an interrogation might clarify time and cause of death.

Methods

Seventy of 4401 patients (1.6%) undergoing autopsy in 2014 and 2015 presented with a CIED. The explanted CIED were interrogated with respect to time and possible cause of death. Battery and lead parameters, clinical and technical alerts, and arrhythmia episodes were reviewed and afterwards correlated with the results of autopsy and clinical data.

Results

Twenty-five implantable cardioverter defibrillators (ICD) and 45 pacemaker (PM) devices were analyzed. Death was classified as cardiac by autopsy in 17 of 70 patients. Accordingly, presumably lethal ventricular arrhythmias were documented in six patients (8.6%; 5 ICD, 1 PM). In two of 30 patients with unknown cause of death after autopsy (6.7%), interrogation revealed ventricular tachycardia as potential reason for decease (1 ICD, 1 PM). Postmortem CIED interrogation additionally allowed to make a statement regarding the day of death in 36 patients (51%; 13 ICD, 23 PM). This was in accordance with clinical data or the results of autopsy in nine patients (25%; 3 ICD, 6 PM) or could even clarify the time of death in six patients (16.7%; 4 ICD, 2 PM).

Conclusion

Interrogation of CIED revealed potentially lethal ventricular arrhythmias in 9 of 70 patients investigated and enabled valid estimation of the day of death in 15 patients. We therefore conclude that routinely performed postmortem CIED interrogation may clarify time and cause of death.
Literatur
2.
Zurück zum Zitat Gibson CM, Krucoff M, Kirtane AJ, Rao SV, Mackall JA, Matthews R, Saba S, Waksman R, Holmes D (2014) Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. Am Heart J 168(4):424–429.e421. https://doi.org/10.1016/j.ahj.2014.05.010 CrossRef Gibson CM, Krucoff M, Kirtane AJ, Rao SV, Mackall JA, Matthews R, Saba S, Waksman R, Holmes D (2014) Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. Am Heart J 168(4):424–429.e421. https://​doi.​org/​10.​1016/​j.​ahj.​2014.​05.​010 CrossRef
4.
Zurück zum Zitat Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793–2867. https://doi.org/10.1093/eurheartj/ehv316 CrossRef Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793–2867. https://​doi.​org/​10.​1093/​eurheartj/​ehv316 CrossRef
5.
Zurück zum Zitat Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, CEGftmopwvaatposcd L, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE (2014) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed) 67(1):58. https://doi.org/10.1016/j.rec.2013.11.003 Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, CEGftmopwvaatposcd L, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE (2014) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed) 67(1):58. https://​doi.​org/​10.​1016/​j.​rec.​2013.​11.​003
Metadaten
Titel
Postmortem interrogation of cardiac implantable electrical devices may clarify time and cause of death
verfasst von
Lisa Riesinger
S. Fichtner
C. G. Schuhmann
H. L. Estner
T. Czermak
M. Graw
F. Fischer
K. Lackermair
Publikationsdatum
20.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 3/2019
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-018-1932-3

Weitere Artikel der Ausgabe 3/2019

International Journal of Legal Medicine 3/2019 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin